Subscribe to our newsletter to be the first to hear about our innovative treatments and special offers.
As a part of our persistent, relentless approach to help our patients suffering from treatment resistant depression (TRD), alongside providing rTMS we are proud to announce we are the first private Esketamine clinic in the North West of the UK.
Esketamine nasal spray has recently been licensed by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK as a treatment for moderate to severe treatment resistant depression that is also referred to as “difficult to treat depression”.
Esketamine nasal spray is the first licensed antidepressant in 30 years with a different mechanism of action from other available antidepressants as it works on the glutamate system of the brain. What is also remarkable is the fact that some patients start feeling an improvement of their depressive symptoms as early as 24 hours from the first dose.
Patients will go through a detailed assessment with a Consultant Psychiatrist to assess suitability for Esketamine. Following this, they will need to come to clinic twice a week for the first 4 weeks, followed by once a week for the following 4 weeks. After this, the treatment options would be discussed with the Consultant Psychiatrist as per client’s preference and needs. All treatments are supervised by our healthcare professionals and patients could leave in approximately 2 hours post treatment once the readiness to leave checklist is completed and your health care professional is satisfied.
Esketamine is indicated for adults with treatment-resistant Major Depressive Disorder who have not responded to at least two different treatments with antidepressants in the current moderate-to-severe depressive episode.
Esketamine cost varies depending on the dose prescribed. Please contact our team for further information.
Yes. We have several patients who utilise all of our treatment services to optimise their recovery. We usually run Esketamine and TMS combined treatments for patients suffering from treat resistant depression and have had some fantastic recovery results using this method.
Esketamine has shown to eliminate suicidality within 24 hours in some cases. Here in clinic, we have seen some rapid improvements to patient’s symptoms. In some cases, it can take a little longer for patients to respond. This can depend on multiple factors. All patients are reviewed weekly by the consultant psychiatrist in the initial stage of treatment to ensure dose and optimisation of treatment effects.
No. As Esketamine is a controlled 2 medication, it is self-administered and supervised by a qualified professional.
The patient is required to stay in clinic for at least 90 minutes post administration. This is to allow time for the side effects to have worn off prior to discharge.
Yes. The side effects of Esketamine peak at roughly 45 minutes post administration but are generally much less after 90 minutes. There is a requirement that patients do not drive post treatment or operate any machinery until the following day.
On the day of treatment, it is a requirement for patients NOT to eat 2 hours prior to their appointment and NOT to have any fluids 30 minutes prior to treatment. Patients can take their usual medications if more than 2 hours prior to treatment and if those medications are not sedative.
Esketamine is broken down into three stages;
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.